Showing results (1511-1520 of 2,100) with videos related to

Sort By:
Pageof 210
Psychoneuroendocrinology|November 7, 2024
Elevated testosterone and prosocial behavior in female patients with borderline personality disorder independent of social exclusionLivia Graumann, Eugenia Kulakova, An Bin Cho, et al.
Intensive Care Medicine Experimental|December 18, 2020
Metabolic substrate utilization in stress-induced immune cellsXiaomin Zhang, Fabian Zink, Felix Hezel, et al.
Journal of Fish Biology|February 4, 2016
The influence of status and the social environment on energy stores in a social fishJ K Hellmann, I Y Ligocki, C M O'Connor, et al.
Clinical Cardiology|January 26, 2021
Hospitalization deficit of in- and outpatient cases with cardiovascular diseases and utilization of cardiological interventions during the COVID-19 pandemic: Insights from the German-wide helios hospital networkSebastian König, Laura Ueberham, Vincent Pellissier, et al.
Proteomics. Clinical Applications|December 8, 2010
Sample handling for mass spectrometric proteomic investigations of human urineAnette Lykke Petri, Claus Høgdall, Ib Jarle Christensen, et al.
Clinical Pharmacokinetics|November 18, 2011
Effect of cytochrome P450 3A4 inducers on the pharmacokinetic, pharmacodynamic and safety profiles of bortezomib in patients with multiple myeloma or non-Hodgkin's lymphomaAndrzej Hellmann, Simon Rule, Jan Walewski, et al.
Anticancer Research|September 1, 1991
Multiple differences between wild-type B16 melanoma cells and a wheat germ agglutinin resistant cloneS Di Virgilio, K P Hellmann, P Robberecht, et al.
Journal of Cardiothoracic and Vascular Anesthesia|June 1, 1997
Direct effects of triiodothyronine on human internal mammary artery and saphenous veinsL J Krasner, W W Wendling, S C Cooper, et al.
The Journal of Infectious Diseases|July 7, 2000
Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconverters in the United States, 1993-1998H Weinstock, R Respess, W Heneine, et al.
The Journal of Infectious Diseases|May 6, 1999
Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcomeS G Deeks, N S Hellmann, R M Grant, et al.
Pageof 210